These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6794355)

  • 21. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
    Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
    Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombocytosis and thrombocythemia.
    Mitus AJ; Schafer AI
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):157-78. PubMed ID: 2155903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential diagnosis of thrombocytosis and thrombocythemia].
    Schoot G
    Z Gesamte Inn Med; 1972 May; 27(10):442-8. PubMed ID: 5054667
    [No Abstract]   [Full Text] [Related]  

  • 24. [The O'Brien filter test in the differential diagnosis of disorders with high-grade thrombocytosis].
    Rejtö L; Schlammadinger A; László P; Kiss A; Telek B; Boda Z
    Orv Hetil; 1998 Aug; 139(33):1961-4. PubMed ID: 9734213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Platelet Distribution Width Be Used to Predict the Possibility of Chronic Myeloproliferative Neoplasms?
    Chandrashekar V; Tarigopula A
    Lab Med; 2019 Apr; 50(2):174-179. PubMed ID: 30329092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytosis in children.
    Chiarello P; Magnolia M; Rubino M; Liguori SA; Miniero R
    Minerva Pediatr; 2011 Dec; 63(6):507-13. PubMed ID: 22075805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 29. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
    Ryningen A; Apelseth T; Hausken T; Bruserud Ø
    Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels.
    Español I; Hernández A; Cortés M; Mateo J; Pujol-Moix N
    Haematologica; 1999 Apr; 84(4):312-6. PubMed ID: 10190944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B; Meuthen I
    Dtsch Med Wochenschr; 1986 Feb; 111(9):329-32. PubMed ID: 3948731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
    Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
    Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of thrombocytosis in critically ill patients and its association with symptomatic acute pulmonary embolism. A multicentre registry study.
    Ho KM; Chavan S
    Thromb Haemost; 2013 Feb; 109(2):272-9. PubMed ID: 23238075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
    Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
    Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal platelet function in myeloproliferative disorders.
    Waddell CC; Brown JA; Repinecz YA
    Arch Pathol Lab Med; 1981 Aug; 105(8):432-5. PubMed ID: 6894852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey.
    Koren-Michowitz M; Lavi N; Ellis MH; Vannucchi AM; Mesa R; Harrison CN
    Ann Hematol; 2017 Jan; 96(1):87-92. PubMed ID: 27734130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.